Abstract:453 Background: Endogenous retroviruses (ERVs) represent 5-8% of the human genome, and their expression in cancer cells correlates with response to immunotherapy in clear cell renal cell carcinoma (ccRCC). Whether this association also exists in papillary renal cell carcinoma (PRCC) is unknown. Studying ERV expression in PRCC and its impact on the tumor microenvironment (TME) may help elucidate its role in PRCC response to immunotherapy. Methods: We quantified ERV expression on human PRCC tissue samples using real-time quantitative PCR (RT-qPCR). ERV4700 was selected due its correlation with response to immunotherapy when expressed in ccRCC. In addition, we stained matched human FFPE tissue with 31 antibodies using multiplex immunohistochemistry (mxIHC) to investigate the TME. Using mxIHC protein expression levels, we generated a probabilistic cell classification algorithm to quantify immune cells. We investigated associations between ERV expression data, clinicopathologic variables, and immune cell proportions in the tumor samples using linear regression. Results: We performed ERV expression and mxIHC analysis on 104 PRCC nephrectomy samples from 1997-2016. After quality control, 78 unique patient tumor samples had results from both pipelines. Median patient age was 65 (IQR 56-71), 74.4% were male, and Fuhrman grade was 1 in 3.9%, 2 in 5.9%, 3 in 50.0%, and 4 in 9.0% of patients. Over a median follow-up of 3.03 years (IQR 0.61-6.99 years), 11.5% had recurrence after definitive local therapy, and 7.7% had an RCC-related death. Increased ERV expression correlated with increasing Fuhrman grade (r = 0.057, p <0.001), but not with disease recurrence or RCC-related death. Increased ERV expression was also associated with an increased TME proportion of cytotoxic T cells, memory T cells, and CD20+ B cells, and with a decreased TME proportion of macrophages (see Table 1). Conclusions: Higher expression of ERV4700 correlates with increased proportions of cytotoxic T cells in the TME of PRCC samples. Given its association with immunotherapy response in ccRCC, further studies are warranted to study ERV expression as a prognostic and predictive biomarker in PRCC. [Table: see text]

The impact of wound-healing assay, phorbol myristate acetate (PMA) stimulation and siRNA-mediated FURIN gene silencing on endogenous retroviral ERVW-1 expression level in U87-MG astrocytoma cells

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization

Activation of endogenous retrovirus triggers microglial immuno-inflammation and contributes to negative emotional behaviors in mice with chronic stress

Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

The Differing Fortunes and miRNA Clusters Between Human Astrocytes and Neurons After Endoplasmic Reticulum Stress With Downregulation of <i>EIF2B5</i>

Comparing Viral Vectors and Fate Mapping Approaches for Astrocyte-to-Neuron Reprogramming in the Injured Mouse Cerebral Cortex

Activation of endogenous retroviruses during brain development causes an inflammatory response

Decoding Neurological Mysteries: the Potential Impact of Endogenous Retroviruses on Brain Health

Endogenous retroviral ERVH48-1 promotes human urine cell reprogramming

Endogenous retroviruses are associated with hippocampus-based memory impairment

383 Epigenetic Potentiation of Anti-tumor Immune Responses Using Viral Mimicry for Gliomas

Identification of Differentially Expressed Human Endogenous Retrovirus Families in Human Leukemia and Lymphoma Cell Lines and Stem Cells

Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease

Activation of endogenous retroviruses during brain development causes neuroinflammation

An In Vitro Study on Human Retinal Astrocytes

[Endogenous retroviral sequences in the human genome can play a physiological or pathological role]

Endogenous retrovirus expression and its impact on tumor-infiltrating immune cells in papillary renal cell carcinoma.

Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases

Epco-13. Human Endogenous Retrovirus (Herv) Plays A Critical Role In Oncogenic Mechanism Inidh1-Wild Type Glioblastomas

A Replication-Competent Retroviral Vector Expressing the HERV-W Envelope Glycoprotein is a Potential Tool for Cancer Gene Therapy